# "Ozempic face": what it is, and where the weight comes from

Source: https://pepvault.app/guides/ozempic-face

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# "Ozempic face": what it is, and where the weight comes from

Reviewed November 2026 18 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

"Ozempic face" is the face losing fat with the body. What the trials' scans show about where GLP-1 weight comes from, and the one study that measured faces.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 18
- **Questions:** 8
- **Compounds:** 2

## The short answer

"Ozempic face" is a nickname, not a diagnosis: a hollower, looser-looking face after a large weight loss. In the trials' body scans, about two-thirds to three-quarters of the weight lost on a GLP-1 was fat, and the face loses fat with the body. The one study that measured faces on the drug found about 7% less midface volume per 10 kg lost. Surgery and diets do the same.

Every number checked at its primary source · Nov 20, 2026 · [18 sources](https://pepvault.app/guides/ozempic-face#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Body composition from DXA substudies of two phase 3 randomised trials (STEP 1, SURMOUNT-1); the face from one retrospective imaging study of 20 people on a GLP-1, bariatric cohort studies and a systematic review, an MRI substudy of a diet trial, twin studies, patient surveys, one preprint, a small tissue study and reviews. No randomised trial has measured the face on a GLP-1.

## What is "Ozempic face"?

It is a social-media name for the face changing during a big weight loss on a GLP-1 drug: hollower cheeks, deeper folds around the mouth, looser skin along the jaw, and an older look. It is not a medical diagnosis, and the reviews that study it point out that the name implies a drug-specific side effect when the same changes follow other large weight losses[1](https://pepvault.app/guides/ozempic-face#source-1) [2](https://pepvault.app/guides/ozempic-face#source-2). A 2025 review found that searches for the term rose alongside searches for face filler and plastic surgeons[3](https://pepvault.app/guides/ozempic-face#source-3).

The plain mechanism is the weight loss itself. The face holds fat in pads under the skin, like the rest of the body. When body fat falls, those pads shrink, and skin that was stretched over them has less underneath it[1](https://pepvault.app/guides/ozempic-face#source-1). Ozempic is semaglutide, a GLP-1 receptor agonist: a copy of a gut hormone that turns appetite down. Mounjaro and Zepbound are tirzepatide, which acts on GLP-1 and a second gut-hormone receptor, GIP.

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

In PepVault, the Body page logs your weight and keeps face check-ins (one dated front photo each), and can set any two check-ins side by side.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Where does the weight come from on a GLP-1?

Mostly fat. Two of the main obesity trials scanned a subgroup with DXA, a low-dose X-ray scan that splits the body into fat, bone and lean mass (muscle, organs and water). In STEP 1, the 83 scanned people on semaglutide 2.4 mg lost 9.3 kg of fat and 5.8 kg of lean mass over 68 weeks[4](https://pepvault.app/guides/ozempic-face#source-4). In SURMOUNT-1, the 124 scanned people on tirzepatide lost 33.9% of their fat mass and 10.9% of lean mass over 72 weeks, and about 75% of the weight lost was fat[5](https://pepvault.app/guides/ozempic-face#source-5).

| Trial (DXA group) | Weeks | Fat lost | Lean mass lost | Fat share of the loss |
| --- | --- | --- | --- | --- |
| STEP 1, semaglutide 2.4 mg (83 people) | 68 | 9.3 kg | 5.8 kg | About 62%[4](https://pepvault.app/guides/ozempic-face#source-4) |
| SURMOUNT-1, tirzepatide 5 to 15 mg (124 people) | 72 | 33.9% of fat mass | 10.9% of lean mass | About 75%[5](https://pepvault.app/guides/ozempic-face#source-5) |
| SURMOUNT-1, placebo with diet advice (36 people) | 72 | 8.2% of fat mass | 2.6% of lean mass | About 75%[5](https://pepvault.app/guides/ozempic-face#source-5) |

Look at the placebo bar: diet alone lost weight in the same three-to-one split as tirzepatide.

The placebo row is the useful one. People in SURMOUNT-1 who took no drug and lost weight on diet and activity advice lost it in the same 75-to-25 split as people on tirzepatide; they simply lost less[5](https://pepvault.app/guides/ozempic-face#source-5). In this trial, the drug changed how much weight came off, not what it was made of. Neither trial scanned the face: DXA reports the whole body and its main regions.

STEP 1's share is worked out from the trial's own kilogram results (9.3 kg of fat out of 15.1 kg of fat and lean mass). The trials ran in different people for different lengths of time, so the two drugs' shares are not a head-to-head comparison. STEP 1's placebo group (39 people) lost about 3 kg in all, too little to read a split from[4](https://pepvault.app/guides/ozempic-face#source-4).

## Has any study measured the face on a GLP-1?

One study has measured how the face itself changes on a GLP-1, as of November 2026. At Vanderbilt University Medical Center, surgeons searched the hospital's records for people with a GLP-1 prescription and a head or neck CT or MRI scan from both before and after they started, and measured the midface (the cheeks, between the eyes and the mouth) on each scan[6](https://pepvault.app/guides/ozempic-face#source-6). Twenty people qualified, with a median age of 54. They had been on the drug for about 321 days on average and had lost 11.0 kg[6](https://pepvault.app/guides/ozempic-face#source-6).

- Total midface volume fell by a median of 9%[6](https://pepvault.app/guides/ozempic-face#source-6).
- The shallow fat layer just under the skin fell 11%, the deeper layer 7%[6](https://pepvault.app/guides/ozempic-face#source-6).
- The more weight a person lost, the more of the shallow layer went; the deep layer did not track weight loss[6](https://pepvault.app/guides/ozempic-face#source-6).
- Across the group, the face lost about 7% of its midface volume for every 10 kg of body weight lost[6](https://pepvault.app/guides/ozempic-face#source-6).

The shallow fat layer under the skin shrank more than the deep one, and it is the layer that tracked weight loss.

It is a small study of scans already in people's records, with no group of people losing the same weight without the drug, so it shows how much the face changes with the weight, not whether the drug adds anything of its own[6](https://pepvault.app/guides/ozempic-face#source-6). No randomised trial of a GLP-1 drug has measured the face; the controlled studies registered so far test a face treatment in people already on one, and none has reported. A questionnaire for rating your own face on a GLP-1, a short form of the FACE-Q scale, was validated in 2026 in 632 people considering, taking or past one, so future trials have a tool to ask[18](https://pepvault.app/guides/ozempic-face#source-18).

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [GIP](https://pepvault.app/glossary/gip)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)
- [Lean mass](https://pepvault.app/glossary/lean-mass)

## Does the same thing happen after bariatric surgery or a diet?

Yes, and it was described long before the name. A 2023 systematic review of four studies, 129 people after bariatric surgery, found facial sagging alongside the weight loss, and judged the evidence still thin[7](https://pepvault.app/guides/ozempic-face#source-7). In Germany, 3D face scans of 23 people before and six months after surgery showed the distances from the ear to the chin shrinking and the neck losing about 75 mL of volume on average, and the neck's loss did not line up with total weight lost[8](https://pepvault.app/guides/ozempic-face#source-8).

Diet alone does it too. In the CENTRAL trial, 278 adults with abdominal obesity, mostly men, were put on low-fat or Mediterranean low-carb diets and followed for 18 months with whole-body MRI. After six months the fat under the skin of the neck had fallen 13.1% and under the chin 5.3%, and the 18-month changes tracked weight loss[9](https://pepvault.app/guides/ozempic-face#source-9).

How the face reads depends on more than the fat. In a Boston study, survey respondents rated photos of 14 people before and after bariatric surgery: overall they looked more attractive afterwards, while only five changed significantly in perceived age, three looking older and two younger[10](https://pepvault.app/guides/ozempic-face#source-10).

## Is it the drug or the weight loss?

The weight loss, on the evidence so far. A 2026 review of 46 reports concluded that the changes are best explained as weight-loss deflation laid over a person's own anatomy and age, the same picture seen after surgery, and that the role of how fast the weight comes off is still unknown[1](https://pepvault.app/guides/ozempic-face#source-1).

Two early studies keep the question open. A records study of women with diabetes and high blood pressure, posted as a preprint and not yet peer-reviewed, found upper-eyelid surgery about twice as common over five years in GLP-1 users as in matched non-users (0.41% against 0.15% of women; hazard ratio 2.22), while weight loss without the drug showed no clear link[11](https://pepvault.app/guides/ozempic-face#source-11). And in 10 tissue samples of belly fat, people on a GLP-1 had about a quarter as many fat-tissue stem cells as untreated controls[12](https://pepvault.app/guides/ozempic-face#source-12). Neither measured a face, and neither shows a drug effect on facial fat.

## Who notices it most?

Older people and those who lose the most. In a US survey of 504 adults on a GLP-1 drug, tirzepatide included, mostly women with an average age of 53 and run by a cosmetics company's research team, 10.9% reported facial volume loss, 8.3% sagging and 7.7% jowls; skin changes were linked to being over 55 and to losing more than 20 lb (9.1 kg)[13](https://pepvault.app/guides/ozempic-face#source-13). In a second survey of 1,226 telemedicine patients, concerns such as facial volume loss rose with the amount of weight lost[14](https://pepvault.app/guides/ozempic-face#source-14).

Age changes what fat does for the face. In a study of 186 pairs of identical twins, the heavier twin looked older below age 40 and younger above it, for a four-point difference in BMI (body mass index)[15](https://pepvault.app/guides/ozempic-face#source-15). Among Danish twins over 70, a low BMI went with looking older[16](https://pepvault.app/guides/ozempic-face#source-16). Facial fat reads as youth later in life, which fits the surveys and reviews finding the change most visible in older people[1](https://pepvault.app/guides/ozempic-face#source-1) [13](https://pepvault.app/guides/ozempic-face#source-13).

**Commonly reported:** noticing it first in photos rather than the mirror, cheeks and temples going first, friends commenting on looking tired while the scale is going the right way, and the face settling once weight holds steady. In the survey of 504 users, 92% were satisfied with their treatment and 84% reported a better body image[13](https://pepvault.app/guides/ozempic-face#source-13).

## What does the dermatology literature describe for it?

Mostly volume and skin treatments borrowed from post-weight-loss care: fillers, collagen-stimulating injectables, radiofrequency devices and topical products[17](https://pepvault.app/guides/ozempic-face#source-17). A 2026 systematic review found four studies of them in facial change after weight loss, two in GLP-1 users only, 98 treated people in all, none with a comparison group, and concluded the evidence is too preliminary to say what works best[17](https://pepvault.app/guides/ozempic-face#source-17). This is a description of the literature, not a recommendation, and whether to treat a change in appearance at all is a choice for you and a dermatologist.

What the evidence does support is that facial fat tends to follow body fat. The weight change is the thing that moves the face, which is why the change shows up with every method of losing a lot of weight[1](https://pepvault.app/guides/ozempic-face#source-1) [7](https://pepvault.app/guides/ozempic-face#source-7) [9](https://pepvault.app/guides/ozempic-face#source-9).

## How do you track how your face is changing?

Mirrors and casual selfies mislead: light, angle and the lens's distance all change how full a face looks. Comparable photos and a weight log show whether the face is following the scale.

1. Stand facing a window at the same time of day, so the light falls the same way every time.
2. Hold the phone at eye level, at arm's length, with your face straight on and a neutral expression.
3. Take one photo before your first dose (or today, if you have started), then one every four weeks on the same day you weigh in.
4. Compare each photo with the first, not with last week's, alongside the weight you lost in between.

<!--promo-->

In PepVault, the Body page logs your weight and keeps face check-ins (one dated front photo each), and can set any two check-ins side by side. [Track your weight in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-ozempic-face-inline&mt=8)

<!--/promo-->

**When to get help** If the weight is coming off much faster than your plan, or you are eating so little that you feel weak or dizzy, tell your prescriber.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Yoo KH. Glucagon-like peptide-1 receptor agonist-associated facial changes: a comprehensive review of pathophysiology, clinical manifestations, risk factors, prevention, and management. Aesthet Surg J. 2026 (online ahead of print). [PubMed 42872378](https://pubmed.ncbi.nlm.nih.gov/42872378/)
2. Carboni A, Woessner S, Martini O, Marroquin NA, Waller J. Natural weight loss or "Ozempic face": demystifying a social media phenomenon. J Drugs Dermatol. 2024;23(1):1367-1368. [PubMed 38206146](https://pubmed.ncbi.nlm.nih.gov/38206146/)
3. Daneshgaran G, Shauly O, Gould DJ. "Ozempic face" in plastic surgery: a systematic review of the literature on GLP-1 receptor agonist mediated weight loss and analysis of public perceptions. Aesthet Surg J Open Forum. 2025;7:ojaf056. [PubMed 40626110](https://pubmed.ncbi.nlm.nih.gov/40626110/)
4. Novo Nordisk A/S. STEP 1: semaglutide 2.4 mg in adults with overweight or obesity (NCT03548935). ClinicalTrials.gov results: change in total fat mass and lean body mass (kg) by DXA, week 0 to 68. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03548935)
5. Look M, Dunn JP, Kushner RF, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab. 2025;27(5):2720-2729. [PubMed 39996356](https://pubmed.ncbi.nlm.nih.gov/39996356/)
6. Sharma RK, Vittetoe KL, Barna AJ, et al. Radiographic midfacial volume changes in patients on GLP-1 agonists. Otolaryngol Head Neck Surg. 2025;173(2):360-366. [PubMed 40407186](https://pubmed.ncbi.nlm.nih.gov/40407186/)
7. Wong ZY, Ramasamy P, Ingels KJAO, et al. Changes of facial features after bariatric surgery: a systematic review. Obes Surg. 2023;33(1):332-338. [PubMed 36434358](https://pubmed.ncbi.nlm.nih.gov/36434358/)
8. Peters F, Kroh A, Neumann UP, et al. Morphological changes of the human face after massive weight-loss due to bariatric surgery. J Craniomaxillofac Surg. 2020;48(7):694-699. [PubMed 32513431](https://pubmed.ncbi.nlm.nih.gov/32513431/)
9. Tsaban G, Bilitzky-Kopit A, Yaskolka Meir A, et al. The effect of weight-loss interventions on cervical and chin subcutaneous fat depots; the CENTRAL randomized controlled trial. Nutrients. 2021;13(11):3827. [PubMed 34836081](https://pubmed.ncbi.nlm.nih.gov/34836081/)
10. Papoian V, Mardirossian V, Hess DT, Spiegel JH. Effects of bariatric surgery on facial features. Arch Plast Surg. 2015;42(5):567-571. [PubMed 26430627](https://pubmed.ncbi.nlm.nih.gov/26430627/)
11. Almeida VFA, Ha J, Duraes F, et al. Use of GLP-1 receptor agonists is associated with an increased rate of upper eyelid blepharoplasty. Res Sq [preprint, not peer-reviewed]. 2026. [PubMed 42245794](https://pubmed.ncbi.nlm.nih.gov/42245794/)
12. Firsowicz M, Kamrani P, Zubair R, et al. Cutaneous variations in stem-cell population in those on GLP1-receptor agonists: a comparative controlled study. Dermatol Surg. 2026;52(6S):S39-S44. [PubMed 42210886](https://pubmed.ncbi.nlm.nih.gov/42210886/)
13. Olivero JW, Paturi J, Moreau M, et al. Dermatological, trichological and quality of life consequences of GLP-1 receptor agonist-mediated weight loss: a US cross-sectional survey. J Cosmet Dermatol. 2026;25(8):e71145. [PubMed 43047060](https://pubmed.ncbi.nlm.nih.gov/43047060/)
14. Santiago Mangual KP, Midura I, Patin E, et al. Aesthetic, muscle, and dermatologic effects of medical weight management: patient-reported outcomes shape a holistic preventive procedural approach. Int J Womens Dermatol. 2026;12(3):e283. [PubMed 42639588](https://pubmed.ncbi.nlm.nih.gov/42639588/)
15. Guyuron B, Rowe DJ, Weinfeld AB, et al. Factors contributing to the facial aging of identical twins. Plast Reconstr Surg. 2009;123(4):1321-1331. [PubMed 19337100](https://pubmed.ncbi.nlm.nih.gov/19337100/)
16. Rexbye H, Petersen I, Johansens M, et al. Influence of environmental factors on facial ageing. Age Ageing. 2006;35(2):110-115. [PubMed 16407433](https://pubmed.ncbi.nlm.nih.gov/16407433/)
17. Maglitto F, Salzano G, Trotta S, et al. Beyond weight loss: facial remodeling associated with GLP-1 receptor agonists. A systematic review and therapeutic framework. Aesthetic Plast Surg. 2026 (online ahead of print). [PubMed 42864543](https://pubmed.ncbi.nlm.nih.gov/42864543/)
18. Klassen AF, Gallo L, Dayan S, et al. Measuring facial appearance in GLP-1 agonist use with the FACE-Q Aesthetics item library. Aesthet Surg J. 2026 (online ahead of print). [PubMed 42140744](https://pubmed.ncbi.nlm.nih.gov/42140744/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)

Foundayo (orforglipron) is a daily GLP-1 pill, not a peptide. Its ATTAIN and ACHIEVE results beside Zepbound's SURMOUNT and Wegovy's STEP, in one table.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)

## Related guides

- Guide · GLP-1s

  ### [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)

  What to expect on tirzepatide week by week: the label's dose steps, when appetite and nausea change, weight loss from week 20 to year 3, and the plateau.

  Read the guide
- Guide · GLP-1s

  ### [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)

  What to expect on retatrutide week by week: the trial dose steps, when appetite drops, weight loss at weeks 24, 48 and 80, and how side effects settle.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [GIP](https://pepvault.app/glossary/gip)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Body mass index (BMI)](https://pepvault.app/glossary/bmi)
- [Lean mass](https://pepvault.app/glossary/lean-mass)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
